James Foley, PhD
Over 30 years pharmaceutical industry experience spanning R&D, corporate development and licensing. Served as Head of business development and licensing of pharmaceuticals for Japan and Asia/Pacific regions at Bristol Myers Squibb, SmithKline Beecham and GlaxoSmithKline. Extensive longstanding relationships with Japanese pharmaceutical industry. Former member of Board of Directors of Sosei & Co. in Tokyo. Responsible for hundreds of millions of dollars worth of transactions in anti-infectives, inflammation, restenosis and cancer. Ph.D. in Physiology and Pharmacology from Thomas Jefferson University and BA in Biology and Chemistry from Rutgers University.